{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:52Z","timestamp":1787020852602,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06030-x","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:26:18Z","timestamp":1784550378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cabozantinib-related pneumothorax in responsive\u00a0patients with renal cell carcinoma: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-9127","authenticated-orcid":false,"given":"Keiko","family":"Kodaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Inakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kuramochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"2","key":"6030_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/1078-0432.CCR-16-1073","volume":"23","author":"H Singh","year":"2017","unstructured":"Singh H, Brave M, Beaver JA, et al. U.S. Food and Drug Administration approval: Cabozantinib for the treatment of advanced renal cell carcinoma. Clin Cancer Res. 2017;23(2):330\u20135. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1073.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6030_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11912-012-0289-x","volume":"15","author":"U Vaishampayan","year":"2013","unstructured":"Vaishampayan U. Cabozantinib as a novel therapy for renal cell carcinoma. Curr Oncol Rep. 2013;15(2):76\u201382. https:\/\/doi.org\/10.1007\/s11912-012-0289-x.","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"6030_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1200\/JCO.2017.74.7352","volume":"36","author":"B Escudier","year":"2018","unstructured":"Escudier B, Powles T, Motzer RJ, et al. Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial. J Clin Oncol. 2018;36(8):765\u201372. https:\/\/doi.org\/10.1200\/JCO.2017.74.7352.","journal-title":"J Clin Oncol"},{"issue":"7","key":"6030_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254866","volume":"16","author":"H Aiba","year":"2021","unstructured":"Aiba H, Kimura H, Yamada S, et al. Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: A case series analysis. PLoS ONE. 2021;16(7): e0254866. https:\/\/doi.org\/10.1371\/journal.pone.0254866.","journal-title":"PLoS ONE"},{"issue":"2","key":"6030_CR5","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/ijc.IJC_95_21","volume":"61","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Mishra PK, Mukhopadhyay S, et al. Pneumothorax in lung metastasis of advanced soft tissue sarcoma patients treated with oral pazopanib. Indian J Cancer. 2024;61(2):278\u201381.","journal-title":"Indian J Cancer"},{"key":"6030_CR6","unstructured":"CABOMETYX (cabozantinib). UK Summary of Product Characteristics. https:\/\/www.medicines.org.uk\/emc\/medicine\/32431. Accessed 10 Mar 2024."},{"issue":"3","key":"6030_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1634\/theoncologist.2017-0335","volume":"23","author":"M Schmidinger","year":"2018","unstructured":"Schmidinger M, Danesi R. Management of adverse events associated with cabozantinib therapy in renal cell carcinoma. Oncologist. 2018;23(3):306\u201315. https:\/\/doi.org\/10.1634\/theoncologist.2017-0335.","journal-title":"Oncologist"},{"issue":"7","key":"6030_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S1470-2045(16)30107-3","volume":"17","author":"TK Choueiri","year":"2016","unstructured":"Choueiri TK, Escudier B, Powles T, et al. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. Lancet Oncol. 2016;17(7):917\u201327. https:\/\/doi.org\/10.1016\/S1470-2045(16)30107-3.","journal-title":"Lancet Oncol"},{"issue":"2","key":"6030_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30577-1","volume":"20","author":"R Iacovelli","year":"2019","unstructured":"Iacovelli R, Ciccarese C, Mosillo C, et al. Cabozantinib-related pneumothorax in rapidly responding patients with renal cell carcinoma. Lancet Oncol. 2019;20(2): e124. https:\/\/doi.org\/10.1016\/S1470-2045(18)30577-1.","journal-title":"Lancet Oncol"},{"key":"6030_CR10","doi-asserted-by":"publisher","DOI":"10.52768\/2766-7820\/1528","author":"MFM Cavallaro","year":"2021","unstructured":"Cavallaro MFM, Giusto AD, Bigal C, et al. Pneumothorax and lung metastases cavitation during cabozantinib treatment for metastatic clear cell renal cell carcinoma: a clinical case with literature 30 overview. J Clin Imag Med Case Rep. 2021. https:\/\/doi.org\/10.52768\/2766-7820\/1528.","journal-title":"J Clin Imag Med Case Rep"},{"issue":"7","key":"6030_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27338","volume":"14","author":"S Rehman","year":"2022","unstructured":"Rehman S, Ullah H, Nagarajan JS, et al. Pneumothorax as a complication of bevacizumab-containing chemotherapy: a systematic review of case reports. Cureus. 2022;14(7): e27338. https:\/\/doi.org\/10.7759\/cureus.27338.","journal-title":"Cureus"},{"issue":"7","key":"6030_CR12","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1023\/a:1008323632078.","volume":"11","author":"S Srinivas","year":"2000","unstructured":"Srinivas S, Varadhachary G. Spontaneous pneumothorax in malignancy: a case report and review of the literature. Ann Oncol. 2000;11(7):887\u20139. https:\/\/doi.org\/10.1023\/a:1008323632078.","journal-title":"Ann Oncol"},{"issue":"11","key":"6030_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI10259","volume":"106","author":"Y Kasahara","year":"2000","unstructured":"Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000;106(11):1311\u20139. https:\/\/doi.org\/10.1172\/JCI10259.","journal-title":"J Clin Invest"},{"issue":"3","key":"6030_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1378\/chest.09-2292","volume":"138","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Sherman M, Fasihuddin Q, Lund ME. A comprehensive review of spontaneous pneumothorax complicating sarcoma. Chest. 2010;138(3):510\u20138. https:\/\/doi.org\/10.1378\/chest.09-2292.","journal-title":"Chest"},{"issue":"6","key":"6030_CR15","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/annonc\/mdr533","volume":"23","author":"DY Heng","year":"2012","unstructured":"Heng DY, Mackenzie MJ, Vaishampayan UN, et al. Primary anti- vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy. Ann Oncol. 2012;23(6):1549\u2013655. https:\/\/doi.org\/10.1093\/annonc\/mdr533.","journal-title":"Ann Oncol"},{"issue":"12","key":"6030_CR16","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","volume":"10","author":"FM Yakes","year":"2011","unstructured":"Yakes FM, Chen J, Tan J, et al. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. Mol Cancer Ther. 2011;10(12):2298\u2013308. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0264.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"6030_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41556-020-0491-2","volume":"22","author":"J Nishida","year":"2020","unstructured":"Nishida J, Momoi Y, Miyakuni K, et al. Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis. Nat Cell Biol. 2020;22(4):465\u201375. https:\/\/doi.org\/10.1038\/s41556-020-0491-2.","journal-title":"Nat Cell Biol"},{"issue":"10","key":"6030_CR18","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","volume":"16","author":"ME Shaul","year":"2019","unstructured":"Shaul ME, Fridlender ZG. Tumor-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019;16(10):601\u201320. https:\/\/doi.org\/10.1038\/s41571-019-0222-4.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"6030_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-020-00665-8","volume":"20","author":"Y Shao","year":"2020","unstructured":"Shao Y, Wu B, Jia W, et al. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. BMC Urol. 2020;20(1): 90. https:\/\/doi.org\/10.1186\/s12894-020-00665-8.","journal-title":"BMC Urol"},{"issue":"11","key":"6030_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2169\/internalmedicine.50.5016","volume":"50","author":"S Shinji","year":"2011","unstructured":"Shinji S, Kazuyo T. Clinical evaluation of endoscopic bronchial occlusion with silicone spigots or the management of persistent pulmonary air leaks. Intern Med. 2011;50(11):1169\u201373. https:\/\/doi.org\/10.2169\/internalmedicine.50.5016.","journal-title":"Intern Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06030-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:02:00Z","timestamp":1784595720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6030"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06030-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study were\u00a0in accordance with\u00a0the ethical standards of the institutional and national research committee and with\u00a0the the1964\u00a0Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from the patient for the publication of this case report and its accompanying images.","order":1,"name":"Ethics","label":"Ethics approval and consent participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"406"}}